Disc Medicine (NASDAQ:IRON) Stock Price Expected to Rise, Scotiabank Analyst Says
Disc Medicine (NASDAQ:IRON – Get Free Report) had its target price boosted by investment analysts at Scotiabank from $73.00 to $75.00 in a note issued to investors on Monday,Benzinga reports. The firm presently has a “sector outperform” rating on the stock. Scotiabank’s target price suggests a potential upside of 35.53% from the stock’s current price. […]
Disc Medicine (NASDAQ:IRON – Get Free Report) had its target price boosted by investment analysts at Scotiabank from $73.00 to $75.00 in a note issued to investors on Monday,Benzinga reports. The firm presently has a “sector outperform” rating on the stock. Scotiabank’s target price suggests a potential upside of 35.53% from the stock’s current price. […]
